Pipamperone and the treatment of impulsive aggressive behaviour;Pipamperon en de behandeling van impulsief gewelddadig gedrag

Tijdschrift voor Psychiatrie

Volumn 50, Issue 3, 2008, Pages 179-183

  Klaassen, A A G ^a  

^a GGZ Dijk en Duin ^*  (Netherlands)

Author keywords

Aggressiveness; Pipamperone; Treatment

Indexed keywords

PIPAMPERONE;

ARTICLE; BEHAVIOR DISORDER; HUMAN; IMPULSIVE AGGRESSIVE BEHAVIOR; INTERMITTENT EXPLOSIVE DISORDER; MENTAL DEFICIENCY; PERSONALITY DISORDER; PUBLICATION; REFERENCE DATABASE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BUTYROPHENONES; EVIDENCE-BASED MEDICINE; HUMANS; IMPULSIVE BEHAVIOR; META-ANALYSIS AS TOPIC; TREATMENT OUTCOME;

EID: 40949131026     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Amery, W.K., Daris, J. (1970). Pipamperone (Dipiperon, R 3345) bij de behandeling van gedrags- en karakterstoornissen. Een multicentrisch oriënterend onderzoek. Tijdschrift voor Psychiatrie, 12, 403-411.
2. American Psychiatric Association (2004). Diagnostic and Statistical Manual of Mental disorders. (4de druk, tekstrevisie). Washington DC: American Psychiatric Association.
3. Brouwers, R.C., Appelo, M.T., Oei, T.I. (2005). Impulsief gewelddadig gedrag, een literatuuronderzoek. Tijdschrift voor Psychiatrie, 47, 533-542.
4. Deberdt, R. (1976). Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation. Acta Psychiatrica Belgica, 76, 157-166.
5. Haegeman, J., Duyck, F. (1978). A retrospective evaluation of pipamperone (Dipiperon) in the treatment of behavioural deviations in severely mentally handicapped. Acta Psychiatrica Belgica, 78, 392-8.
6. Harten, P.N. van (2003). Acute bewegingsstoornissen door medicijnen. Tijdschrift voor Psychiatrie, 45, 251-263.
7. Hemert, J.C. van (1975). Pipamperone (Dipiperon, R3345) in troublesome mental retardates: a double-blind placebo controlled cross-over study with long-term follow-up. Acta Psychiatrica Scandinavia, 52, 237-245.
8. Hollander, E., Swann, A.C., Coccaro, E.F., e.a. (2005). Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. The American Jour nal of Psychiatry, 162, 621-624.
9. La Malfa, G., Lassi, S., Bertelli, M. (2006). Reviewing the use of antipsychotic drugs in people with intellectual disability. Human Psychopharmacology, 21, 73-89.
10. Noordhuizen, G.J. (1977). Treating severe maladjustment with pipamperone (Dipiperon). Acta Psychiatrica Belgica, 77, 754-760.
11. Potgieter, G.E., Groenewoud, G., Jordaan, P.J., e.a. (2002). Pharmacokinetics of pipamperone from three different tablet formulations. Arzneimittelforschung/Drug Research, 52, 430-434.
12. Schillevoort, I., Boer, A. de, Herings, R.M.C., e.a. (2001). Antipsychotic-induced extrapyramidal syndroms. European Journal of Clinical Pharmacology, 57, 327-331.
13. Schotte, A., Janssen, P.F.M., Gommeren, W., e.a. (1996). Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology, 124, 57-73.
14. Squelart, P., & Saravia, J. (1977). Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients. Acta Psychiatrica Belgica, 77, 284-293.